Brand: StemEdit™
VCT-37-F35 B2M KO
Human iPSCs with a Knockout in the B2M (HLA Class I) gene
VCT-37-F35 B2M CIITA
Human iPSCs with Knockouts in the B2M (HLA Class I) and CIITA (HLA Class II) genes.
Meet us next:
ELRIG – Drug Discovery in Scotland 2025 – 17 September ●
The Cell & Gene Meeting on the Mesa 2025 – 6-8 October (in person) & 9-10 October (virtual) ●
ESGCT Congress 2025 – 7-10 October ●
ELRIG – Drug Discovery – 21-22 October ●
more on our events calendar